WOS: 000245169300013PubMed ID: 17455438Purpose: The aim of this study was to evaluate the clinical performance of all-ceramic crowns made with the IPS Empress 2 system after an observation period of 12 to 60 months. Materials and Methods: Seventy-nine IPS Empress 2 crowns were placed in 21 patients. The all-ceramic crowns were evaluated clinically, radiographically, and using clinical photographs. The evaluations took place at baseline (2 days after cementation) and at 6-month intervals for 12 to 60 months. Survival rate of the crowns was determined using Kaplan-Meier statistical analysis. Results: Based on the US Public Health Service criteria, 95.24% of the crowns were rated satisfactory after a mean follow-up period of 58 months. Fractur...
The aim of this study was to evaluate the performance of IPS Empress ceramic onlays luted with two d...
Background and Objectives: One of the most commonly used restorations for teeth with severe crown de...
Purpose: To investigate the clinical performance and clinical survival rate of lithium disilicate-ba...
Objectives. The aim of this study was to evaluate the clinical performance of crowns and fixed parti...
Purpose: The aim of this study was to evaluate the clinical fracture rate of crowns fabricated with ...
This study evaluated the long-term survival of inlays and partial crowns made of IPS Empress. For th...
This study evaluated the long-term survival of inlays and partial crowns made of IPS Empress. For th...
For the dental restorations, ceramic materials have increasing popularities because of their biocomp...
The objective of the study was to evaluate the clinical outcomes of all-ceramic crowns three years a...
All-ceramic restorations have had a more limited life expectancy than metal ceramic restorations bec...
WOS: 000248726700003PubMed ID: 17823668Objective: The Probond metal-ceramic system was proposed as a...
Background: The Procera AllCeram™ system (Nobel Biocare AB, Göteborg, Sweden) is a valid alternative...
WOS: 000351715400002PubMed ID: 25529004Objective: The aim of this prospective clinical study was to ...
WOS: 000220885200003PubMed ID: 15119675The esthetic demands of patients have increased considerably ...
Background: The Procera AllCeram (Nobel Biocare AB, Göteborg, Sweden, and Procera Sandvik AB, Stockh...
The aim of this study was to evaluate the performance of IPS Empress ceramic onlays luted with two d...
Background and Objectives: One of the most commonly used restorations for teeth with severe crown de...
Purpose: To investigate the clinical performance and clinical survival rate of lithium disilicate-ba...
Objectives. The aim of this study was to evaluate the clinical performance of crowns and fixed parti...
Purpose: The aim of this study was to evaluate the clinical fracture rate of crowns fabricated with ...
This study evaluated the long-term survival of inlays and partial crowns made of IPS Empress. For th...
This study evaluated the long-term survival of inlays and partial crowns made of IPS Empress. For th...
For the dental restorations, ceramic materials have increasing popularities because of their biocomp...
The objective of the study was to evaluate the clinical outcomes of all-ceramic crowns three years a...
All-ceramic restorations have had a more limited life expectancy than metal ceramic restorations bec...
WOS: 000248726700003PubMed ID: 17823668Objective: The Probond metal-ceramic system was proposed as a...
Background: The Procera AllCeram™ system (Nobel Biocare AB, Göteborg, Sweden) is a valid alternative...
WOS: 000351715400002PubMed ID: 25529004Objective: The aim of this prospective clinical study was to ...
WOS: 000220885200003PubMed ID: 15119675The esthetic demands of patients have increased considerably ...
Background: The Procera AllCeram (Nobel Biocare AB, Göteborg, Sweden, and Procera Sandvik AB, Stockh...
The aim of this study was to evaluate the performance of IPS Empress ceramic onlays luted with two d...
Background and Objectives: One of the most commonly used restorations for teeth with severe crown de...
Purpose: To investigate the clinical performance and clinical survival rate of lithium disilicate-ba...